Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Kolibianakis EM, et al. Among authors: van steirteghem ac. Fertil Steril. 2004 Jul;82(1):102-7. doi: 10.1016/j.fertnstert.2004.01.027. Fertil Steril. 2004. PMID: 15236997 Free article. Clinical Trial.
Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy.
Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Kolibianakis EM, et al. Among authors: van steirteghem ac. Fertil Steril. 2003 Apr;79(4):873-80. doi: 10.1016/s0015-0282(02)04920-8. Fertil Steril. 2003. PMID: 12749423 Free article. Clinical Trial.
Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
Kolibianakis EM, Bourgain C, Platteau P, Albano C, Van Steirteghem AC, Devroey P. Kolibianakis EM, et al. Among authors: van steirteghem ac. Fertil Steril. 2003 Aug;80(2):464-6. doi: 10.1016/s0015-0282(03)00663-0. Fertil Steril. 2003. PMID: 12909519 Free article. No abstract available.
Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles.
Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Kolibianakis EM, et al. Among authors: van steirteghem ac. J Clin Endocrinol Metab. 2003 Dec;88(12):5632-7. doi: 10.1210/jc.2003-030805. J Clin Endocrinol Metab. 2003. PMID: 14671145 Clinical Trial.
Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles.
Kolibianakis EM, Bourgain C, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Kolibianakis EM, et al. Among authors: van steirteghem ac. Hum Reprod. 2005 Sep;20(9):2453-6. doi: 10.1093/humrep/dei069. Epub 2005 May 12. Hum Reprod. 2005. PMID: 15890735 Clinical Trial.
Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Kolibianakis EM, et al. Among authors: van steirteghem ac. Fertil Steril. 2007 Nov;88(5):1382-8. doi: 10.1016/j.fertnstert.2006.12.058. Epub 2007 Apr 18. Fertil Steril. 2007. PMID: 17445806 Free article. Clinical Trial.
520 results